世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

北米のラットモデル市場予測 2019-2027年

NORTH AMERICA RAT MODEL MARKET FORECAST 2019-2027

 

出版社 出版年月電子版価格 ページ数
Inkwood Research
インクウッドリサーチ
2019年1月US$1,250
シングルユーザライセンス(印刷不可PDF)
78

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

サマリー

この調査レポートは北米のラットモデル市場を分析・予測したInkwood Researchの市場調査報告書です。

Overview

KEY FINDINGS
The North-America market is growing at a CAGR of 8.14% for the forecast period of 2019-2027 and is anticipated to generate a revenue of $XX thousand by 2027. The North-American market is expected to hold the lion’s share in the rat model market by the end of the forecast period. The novel discoveries in the methodologies for monoclonal antibodies production, a growing demand for personalized medicines and the subsequent rise in demand for various rat models for research activities are some of the factors which are providing the North-American rat model market with excellent growth opportunities.

MARKET INSIGHTS

Various aspects like new and improved genome editing techniques, increasing research by biotechnological and biopharmaceutical companies and ease of access for the transgenic rat methodologies are acting as the major drivers for the market. The rat model market segmentation depends on various factors such as the type of rat models (inbred, knock-out, hybrid, outbred, etc.), the type of components; which includes the technology used, the service provided and the various rat care products needed during the research, and also on the basis of the application of the models in various medical and research fields. The United States has shown the highest growth in the North American region and is expected to continue its dominance over the forecasted period.

COMPETITIVE INSIGHTS

Because of the presence of major pharmaceutical companies like Roche, Merck & Co., and Novartis in the North American region and their main focus being on pre-clinical trials and clinical research studies, the demand for the rat models have increased considerably in the US. Also, Lab Corp is another such company in the North American market which is now primarily focusing on genomic study. The other companies currently leading the North American rat model market scene are Janvier Labs, Taconic Biosciences, Transposagen Biopharmaceuticals Inc., Charles River Laboratories Inc., Oncodesign S.A., Sage Labs Inc. (Acquired By Horizon Discovery Group PLC), Cyagen Biosciences Inc., Clea Japan, Transviragen Inc., Envigo, Hera Biolabs Inc., Genoway S.A., Vivo Biotech Ltd., Laboratory Corporation of America Holdings and Biomere.



目次

Table of Contents

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. OUTBRED RAT TYPE HOLDS THE MAJOR SHARE IN THE RAT MODEL MARKET
3.2.2. ONCOLOGY IS THE FASTEST GROWING APPLICATION
3.2.3. RAT CARE PRODUCTS ARE SIGNIFICANTLY GROWING
4. MARKET DYNAMICS
4.1. MARKET SCOPE & DEFINITION
4.2. MARKET DRIVERS
4.2.1. ENHANCEMENT IN GENOME EDITING
4.2.2. GROWING AVAILABILITY IN RAT TRANSGENIC
4.2.3. SWELLING PHARMACEUTICAL AND BIOTECHNOLOGY CORPORATIONS R&D
4.3. MARKET RESTRAINTS
4.3.1. UNETHICAL PRACTICE OF ANIMALS IN RESEARCH
4.3.2. FLUCTUATING RULES AND REGULATION ON ANIMAL TESTING
4.3.3. USE OF ZEBRAFISH IN RESEARCH IS THE GROWING MODEL
4.3.4. IN VITRO AND ALTERNATIVE TESTING TECHNIQUES MODELS FOR RESEARCH
4.4. MARKET OPPORTUNITIES
4.4.1. PERSONALIZED MEDICINE ESTABLISHED TO SURGE DEMAND
4.4.2. ESCALATION IN MONOCLONAL ANTIBODY CREATION
4.5. MARKET CHALLENGES
4.5.1. HIGHLY EXPENSIVE RAT MODEL
5. MARKET BY RAT TYPE
5.1. INBRED
5.2. GENETICALLY ENGINEERED RATS
5.3. SURGICALLY MODIFIED RATS
5.4. HYBRID
5.5. OUTBRED
5.6. IMMUNE-DEFICIENT
6. MARKET BY APPLICATION
6.1. DIABETES
6.2. TOXICOLOGY
6.3. ONCOLOGY
6.4. IMMUNOLOGY & INFLAMMATION
6.5. OTHER APPLICATION
7. MARKET BY COMPONENT
7.1. TECHNOLOGY
7.1.1. NUCLEAR TRANSFERASE
7.1.2. MICROINJECTION
7.1.3. EMBRYONIC STEM CELL INJECTION
7.1.4. OTHER TECHNOLOGY
7.2. SERVICES
7.3. RAT CARE PRODUCTS
7.3.1. FEED
7.3.2. BEDDING
7.3.3. CAGES
7.3.4. OTHER RAT CARE PRODUCTS
8. KEY ANALYTICS
8.1. PORTER’S FIVE FORCE MODEL
8.1.1. THREAT OF NEW ENTRANTS
8.1.2. THREAT OF SUBSTITUTE PRODUCT
8.1.3. BARGAINING POWER OF BUYERS
8.1.4. BARGAINING POWER OF SUPPLIERS
8.1.5. INTENSITY OF COMPETITIVE RIVALRY
8.2. VALUE CHAIN ANALYSIS
8.3. REGULATORY FRAMEWORK
8.4. KEY BUYING CRITERIA
8.4.1. HIGH ACCURACY
8.4.2. HIGH EFFICACY
8.4.3. QUALITY OF OPERATING PROCEDURE
8.4.4. PRICE
8.5. OPPORTUNITY MATRIX
9. GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1. THE UNITED STATES
9.1.2. CANADA
10. COMPETITIVE LANDSCAPE
10.1. MARKET POSITION ANALYSIS
10.2. COMPANY PROFILES
10.2.1. BIOMERE
10.2.1.1. COMPANY OVERVIEW
10.2.1.2. PRODUCT PORTFOLIO
10.2.1.3. SCOT ANALYSIS
10.2.2. CHARLES RIVER LABORATORIES INC.
10.2.2.1. COMPANY OVERVIEW
10.2.2.2. PRODUCT PORTFOLIO
10.2.2.3. SCOT ANALYSIS
10.2.2.4. STRATEGIC INITIATIVES
10.2.3. CLEA JAPAN
10.2.3.1. COMPANY OVERVIEW
10.2.3.2. PRODUCT PORTFOLIO
10.2.3.3. SCOT ANALYSIS
10.2.3.4. STRATEGIC INITIATIVES
10.2.4. CYAGEN BIOSCIENCES INC.
10.2.4.1. COMPANY OVERVIEW
10.2.4.2. PRODUCT PORTFOLIO
10.2.4.3. SCOT ANALYSIS
10.2.5. ENVIGO
10.2.5.1. COMPANY OVERVIEW
10.2.5.2. PRODUCT PORTFOLIO
10.2.5.3. STRATEGIC INITIATIVES
10.2.6. GENOWAY S. A.
10.2.6.1. COMPANY OVERVIEW
10.2.6.2. PRODUCT PORTFOLIO
10.2.6.3. SCOT ANALYSIS
10.2.6.4. STRATEGIC INITIATIVES
10.2.7. HERA BIOLABS INC.
10.2.7.1. COMPANY OVERVIEW
10.2.7.2. PRODUCT PORTFOLIO
10.2.7.3. SCOT ANALYSIS
10.2.7.4. STRATEGIC INITIATIVE
10.2.8. JANVIER LABS
10.2.8.1. COMPANY OVERVIEW
10.2.8.2. PRODUCT PORTFOLIO
10.2.8.3. SCOT ANALYSIS
10.2.9. LABORATORY CORPORATION OF AMERICA HOLDINGS
10.2.9.1. COMPANY OVERVIEW
10.2.9.2. PRODUCT PORTFOLIO
10.2.9.3. STRATEGIC INITIATIVES
10.2.10. ONCODESIGN S.A.
10.2.10.1. COMPANY OVERVIEW
10.2.10.2. PRODUCT PORTFOLIO
10.2.10.3. SCOT ANALYSIS
10.2.10.4. STRATEGIC INITIATIVE
10.2.11. SAGE LABS INC. (ACQUIRED BY HORIZON DISCOVERY GROUP PLC.)
10.2.11.1. COMPANY OVERVIEW
10.2.11.2. PRODUCT PORTFOLIO
10.2.11.3. SCOT ANALYSIS
10.2.11.4. STRATEGIC INITIATIVES
10.2.12. TACONIC BIOSCIENCES
10.2.12.1. COMPANY OVERVIEW
10.2.12.2. PRODUCT PORTFOLIO
10.2.12.3. SCOT ANALYSIS
10.2.12.4. STRATEGIC INITIATIVES
10.2.13. TRANSPOSAGEN BIOPHARMACEUTICALS INC
10.2.13.1. COMPANY OVERVIEW
10.2.13.2. PRODUCT PORTFOLIO
10.2.13.3. SCOT ANALYSIS
10.2.13.4. STRATEGIC INITIATIVES
10.2.14. TRANSVIRAGEN INC.
10.2.14.1. COMPANY OVERVIEW
10.2.14.2. PRODUCT PORTFOLIO
10.2.14.3. SCOT ANALYSIS
10.2.15. VIVO BIOTECH LTD.
10.2.15.1. COMPANY OVERVIEW
10.2.15.2. PRODUCT PORTFOLIO
10.2.15.3. SCOT ANALYSIS
10.2.15.4. STRATEGIC INITIATIVES

LIST OF TABLE
TABLE 1 NORTH AMERICA RAT MODEL MARKET 2019-2027 ($ MILLION)
TABLE 2 BENEFITS OF RAT TRANSGENIC
TABLE 3 NORTH AMERICA RAT MODEL MARKET BY RAT TYPE 2019-2027 ($ MILLION)
TABLE 4 EXAMPLES OF INBRED RATS AND RESEARCH APPLICATIONS
TABLE 5 NORTH AMERICA INBRED MARKET 2019-2027 ($ MILLION)
TABLE 6 NORTH AMERICA GENETICALLY ENGINEERED RATS MARKET 2019-2027 ($ MILLION)
TABLE 7 NORTH AMERICA SURGICALLY MODIFIED RATS MARKET 2019-2027 ($ MILLION)
TABLE 8 NORTH AMERICA HYBRID MARKET 2019-2027 ($ MILLION)
TABLE 9 NORTH AMERICA OUTBRED MARKET 2019-2027 ($ MILLION)
TABLE 10 NORTH AMERICA IMMUNE-DEFICIENT MARKET 2019-2027 ($ MILLION)
TABLE 11 NORTH AMERICA RAT MODEL MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 12 NORTH AMERICA DIABETES MARKET 2019-2027 ($ MILLION)
TABLE 13 NORTH AMERICA TOXICOLOGY MARKET 2019-2027 ($ MILLION)
TABLE 14 NORTH AMERICA ONCOLOGY MARKET 2019-2027 ($ MILLION)
TABLE 15 NORTH AMERICA IMMUNOLOGY & INFLAMMATION MARKET 2019-2027 ($ MILLION)
TABLE 16 NORTH AMERICA OTHER APPLICATION MARKET 2019-2027 ($ MILLION)
TABLE 17 NORTH AMERICA RAT MODEL MARKET BY COMPONENT 2019-2027 ($ MILLION)
TABLE 18 NORTH AMERICA TECHNOLOGY MARKET 2019-2027 ($ MILLION)
TABLE 19 NORTH AMERICA NUCLEAR TRANSFERASE MARKET 2019-2027 ($ MILLION)
TABLE 20 NORTH AMERICA MICRO INJECTION MARKET 2019-2027 ($ MILLION)
TABLE 21 NORTH AMERICA EMBRYONIC STEM CELL INJECTION MARKET 2019-2027 ($ MILLION)
TABLE 22 NORTH AMERICA OTHER TECHNOLOGY MARKET 2019-2027 ($ MILLION)
TABLE 23 NORTH AMERICA SERVICES MARKET 2019-2027 ($ MILLION)
TABLE 24 NORTH AMERICA RAT CARE PRODUCTS MARKET 2019-2027 ($ MILLION)
TABLE 25 NORTH AMERICA FEED MARKET 2019-2027 ($ MILLION)
TABLE 26 POPULAR FOOD FOR RATS
TABLE 27 NORTH AMERICA BEDDING MARKET 2019-2027 ($ MILLION)
TABLE 28 NORTH AMERICA CAGES MARKET 2019-2027 ($ MILLION)
TABLE 29 NORTH AMERICA OTHER RAT CARE PRODUCTS MARKET 2019-2027 ($ MILLION)
TABLE 30 NORTH AMERICA RAT MODEL MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 31 RAT MODEL COMPANY POSITION ANALYSIS

LIST OF FIGURES
FIGURE 1 NORTH AMERICA RAT MODEL MARKET 2019-2027 ($ MILLION)
FIGURE 2 NORTH AMERICA RAT MODEL MARKET SHARE BY RAT TYPE 2018 & 2027 (%)
FIGURE 3 NORTH AMERICA RAT MODEL MARKET BY INBRED 2019-2027 ($ MILLION)
FIGURE 4 NORTH AMERICA RAT MODEL MARKET BY GENETICALLY ENGINEERED RATS 2019-2027 ($ MILLION)
FIGURE 5 NORTH AMERICA RAT MODEL MARKET BY SURGICALLY MODIFIED RATS 2019-2027 ($ MILLION)
FIGURE 6 NORTH AMERICA RAT MODEL MARKET BY HYBRID 2019-2027 ($ MILLION)
FIGURE 7 NORTH AMERICA RAT MODEL MARKET BY OUTBRED 2019-2027 ($ MILLION)
FIGURE 8 NORTH AMERICA RAT MODEL MARKET BY IMMUNE-DEFICIENT 2019-2027 ($ MILLION)
FIGURE 9 NORTH AMERICA RAT MODEL MARKET SHARE BY APPLICATION 2018 & 2027 (%)
FIGURE 10 PERCENTAGE OF DIABETES IN WORLD ADULT POPULATION IN 1980, 2015 & 2040
FIGURE 11 NORTH AMERICA RAT MODEL MARKET BY DIABETES 2019-2027 ($ MILLION)
FIGURE 12 NORTH AMERICA RAT MODEL MARKET BY TOXICOLOGY 2019-2027 ($ MILLION)
FIGURE 13 NORTH AMERICA RAT MODEL MARKET BY ONCOLOGY 2019-2027 ($ MILLION)
FIGURE 14 NORTH AMERICA RAT MODEL MARKET BY IMMUNOLOGY & INFLAMMATION 2019-2027 ($ MILLION)
FIGURE 15 NORTH AMERICA RAT MODEL MARKET BY OTHER APPLICATION 2019-2027 ($ MILLION)
FIGURE 16 NORTH AMERICA RAT MODEL MARKET SHARE BY COMPONENT 2018 & 2027 (%)
FIGURE 17 NORTH AMERICA RAT MODEL MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
FIGURE 18 NORTH AMERICA RAT MODEL MARKET BY NUCLEAR TRANSFERASE 2019-2027 ($ MILLION)
FIGURE 19 NORTH AMERICA RAT MODEL MARKET BY MICRO INJECTION 2019-2027 ($ MILLION)
FIGURE 20 NORTH AMERICA RAT MODEL MARKET BY EMBRYONIC STEM CELL INJECTION 2019-2027 ($ MILLION)
FIGURE 21 NORTH AMERICA RAT MODEL MARKET BY OTHER TECHNOLOGY 2019-2027 ($ MILLION)
FIGURE 22 NORTH AMERICA RAT MODEL MARKET BY SERVICES 2019-2027 ($ MILLION)
FIGURE 23 NORTH AMERICA RAT MODEL MARKET BY RAT CARE PRODUCTS 2019-2027 ($ MILLION)
FIGURE 24 NORTH AMERICA RAT MODEL MARKET BY FEED 2019-2027 ($ MILLION)
FIGURE 25 NORTH AMERICA RAT MODEL MARKET BY BEDDING 2019-2027 ($ MILLION)
FIGURE 26 NORTH AMERICA RAT MODEL MARKET BY CAGES 2019-2027 ($ MILLION)
FIGURE 27 NORTH AMERICA RAT MODEL MARKET BY OTHER RAT CARE PRODUCTS 2019-2027 ($ MILLION)
FIGURE 28 PORTER’S FIVE FORCE MODEL
FIGURE 29 THE UNITED STATES RAT MODEL MARKET 2019-2027 ($ MILLION)
FIGURE 30 NATIONAL HUMAN GENOME RESEARCH BUDGET 2017 ($ MILLION)
FIGURE 31 CANADA RAT MODEL MARKET 2019-2027 ($ MILLION)

List of Tables

LIST OF TABLE
TABLE 1 NORTH AMERICA RAT MODEL MARKET 2019-2027 ($ MILLION)
TABLE 2 BENEFITS OF RAT TRANSGENIC
TABLE 3 NORTH AMERICA RAT MODEL MARKET BY RAT TYPE 2019-2027 ($ MILLION)
TABLE 4 EXAMPLES OF INBRED RATS AND RESEARCH APPLICATIONS
TABLE 5 NORTH AMERICA INBRED MARKET 2019-2027 ($ MILLION)
TABLE 6 NORTH AMERICA GENETICALLY ENGINEERED RATS MARKET 2019-2027 ($ MILLION)
TABLE 7 NORTH AMERICA SURGICALLY MODIFIED RATS MARKET 2019-2027 ($ MILLION)
TABLE 8 NORTH AMERICA HYBRID MARKET 2019-2027 ($ MILLION)
TABLE 9 NORTH AMERICA OUTBRED MARKET 2019-2027 ($ MILLION)
TABLE 10 NORTH AMERICA IMMUNE-DEFICIENT MARKET 2019-2027 ($ MILLION)
TABLE 11 NORTH AMERICA RAT MODEL MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 12 NORTH AMERICA DIABETES MARKET 2019-2027 ($ MILLION)
TABLE 13 NORTH AMERICA TOXICOLOGY MARKET 2019-2027 ($ MILLION)
TABLE 14 NORTH AMERICA ONCOLOGY MARKET 2019-2027 ($ MILLION)
TABLE 15 NORTH AMERICA IMMUNOLOGY & INFLAMMATION MARKET 2019-2027 ($ MILLION)
TABLE 16 NORTH AMERICA OTHER APPLICATION MARKET 2019-2027 ($ MILLION)
TABLE 17 NORTH AMERICA RAT MODEL MARKET BY COMPONENT 2019-2027 ($ MILLION)
TABLE 18 NORTH AMERICA TECHNOLOGY MARKET 2019-2027 ($ MILLION)
TABLE 19 NORTH AMERICA NUCLEAR TRANSFERASE MARKET 2019-2027 ($ MILLION)
TABLE 20 NORTH AMERICA MICRO INJECTION MARKET 2019-2027 ($ MILLION)
TABLE 21 NORTH AMERICA EMBRYONIC STEM CELL INJECTION MARKET 2019-2027 ($ MILLION)
TABLE 22 NORTH AMERICA OTHER TECHNOLOGY MARKET 2019-2027 ($ MILLION)
TABLE 23 NORTH AMERICA SERVICES MARKET 2019-2027 ($ MILLION)
TABLE 24 NORTH AMERICA RAT CARE PRODUCTS MARKET 2019-2027 ($ MILLION)
TABLE 25 NORTH AMERICA FEED MARKET 2019-2027 ($ MILLION)
TABLE 26 POPULAR FOOD FOR RATS
TABLE 27 NORTH AMERICA BEDDING MARKET 2019-2027 ($ MILLION)
TABLE 28 NORTH AMERICA CAGES MARKET 2019-2027 ($ MILLION)
TABLE 29 NORTH AMERICA OTHER RAT CARE PRODUCTS MARKET 2019-2027 ($ MILLION)
TABLE 30 NORTH AMERICA RAT MODEL MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 31 RAT MODEL COMPANY POSITION ANALYSIS

List of Figures

LIST OF FIGURES
FIGURE 1 NORTH AMERICA RAT MODEL MARKET 2019-2027 ($ MILLION)
FIGURE 2 NORTH AMERICA RAT MODEL MARKET SHARE BY RAT TYPE 2018 & 2027 (%)
FIGURE 3 NORTH AMERICA RAT MODEL MARKET BY INBRED 2019-2027 ($ MILLION)
FIGURE 4 NORTH AMERICA RAT MODEL MARKET BY GENETICALLY ENGINEERED RATS 2019-2027 ($ MILLION)
FIGURE 5 NORTH AMERICA RAT MODEL MARKET BY SURGICALLY MODIFIED RATS 2019-2027 ($ MILLION)
FIGURE 6 NORTH AMERICA RAT MODEL MARKET BY HYBRID 2019-2027 ($ MILLION)
FIGURE 7 NORTH AMERICA RAT MODEL MARKET BY OUTBRED 2019-2027 ($ MILLION)
FIGURE 8 NORTH AMERICA RAT MODEL MARKET BY IMMUNE-DEFICIENT 2019-2027 ($ MILLION)
FIGURE 9 NORTH AMERICA RAT MODEL MARKET SHARE BY APPLICATION 2018 & 2027 (%)
FIGURE 10 PERCENTAGE OF DIABETES IN WORLD ADULT POPULATION IN 1980, 2015 & 2040
FIGURE 11 NORTH AMERICA RAT MODEL MARKET BY DIABETES 2019-2027 ($ MILLION)
FIGURE 12 NORTH AMERICA RAT MODEL MARKET BY TOXICOLOGY 2019-2027 ($ MILLION)
FIGURE 13 NORTH AMERICA RAT MODEL MARKET BY ONCOLOGY 2019-2027 ($ MILLION)
FIGURE 14 NORTH AMERICA RAT MODEL MARKET BY IMMUNOLOGY & INFLAMMATION 2019-2027 ($ MILLION)
FIGURE 15 NORTH AMERICA RAT MODEL MARKET BY OTHER APPLICATION 2019-2027 ($ MILLION)
FIGURE 16 NORTH AMERICA RAT MODEL MARKET SHARE BY COMPONENT 2018 & 2027 (%)
FIGURE 17 NORTH AMERICA RAT MODEL MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
FIGURE 18 NORTH AMERICA RAT MODEL MARKET BY NUCLEAR TRANSFERASE 2019-2027 ($ MILLION)
FIGURE 19 NORTH AMERICA RAT MODEL MARKET BY MICRO INJECTION 2019-2027 ($ MILLION)
FIGURE 20 NORTH AMERICA RAT MODEL MARKET BY EMBRYONIC STEM CELL INJECTION 2019-2027 ($ MILLION)
FIGURE 21 NORTH AMERICA RAT MODEL MARKET BY OTHER TECHNOLOGY 2019-2027 ($ MILLION)
FIGURE 22 NORTH AMERICA RAT MODEL MARKET BY SERVICES 2019-2027 ($ MILLION)
FIGURE 23 NORTH AMERICA RAT MODEL MARKET BY RAT CARE PRODUCTS 2019-2027 ($ MILLION)
FIGURE 24 NORTH AMERICA RAT MODEL MARKET BY FEED 2019-2027 ($ MILLION)
FIGURE 25 NORTH AMERICA RAT MODEL MARKET BY BEDDING 2019-2027 ($ MILLION)
FIGURE 26 NORTH AMERICA RAT MODEL MARKET BY CAGES 2019-2027 ($ MILLION)
FIGURE 27 NORTH AMERICA RAT MODEL MARKET BY OTHER RAT CARE PRODUCTS 2019-2027 ($ MILLION)
FIGURE 28 PORTER’S FIVE FORCE MODEL
FIGURE 29 THE UNITED STATES RAT MODEL MARKET 2019-2027 ($ MILLION)
FIGURE 30 NATIONAL HUMAN GENOME RESEARCH BUDGET 2017 ($ MILLION)
FIGURE 31 CANADA RAT MODEL MARKET 2019-2027 ($ MILLION)

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る